Navigation Links
Speakers Announced for the 2012 International Iridoid Research Symposium

PROVO, Utah, July 25, 2012 /PRNewswire/ -- The International Society for Iridoid Research announced the speakers for the 3rd annual International Iridoid Research Symposium to be held in Provo, Utah, on August 21st. Scientists from around the world will be presenting current research on iridoids in both plants and animals. The symposium is being held at Morinda Bioactives (formerly Tahitian Noni International) and is dedicated to sharing information and research being conducted on iridoids.


Speakers for the 3rd Annual Iridoid Symposium Include:
Afa Palu – Tonga
The Effects of Nature vs. Nurture on Total Bioactive Iridoids

Dr. Il Moo Chang – Korea
Effect of Combinational Treatment of Gleevec, an Anti-Leukemic Drug with Aucubin

Dr. Bingjiu Xu – China
Advances in Research on Natural Compounds Containing Iridoids

Dr. Ma De Lu – China
Research of Thrive MAX's Preventative Effect on Preclinical Type II Diabetes Model.

Dr. Simla Basar – Germany
Adaptogenic Activity of Iridoids in Tissue Cultures

Dr. Biswanath Dinda – India
Anti-Proprotein Convertase Enzyme Assay of Iridoids and other Natural Products for Evaluation of Anti-Cancer Efficacy and Bioactivities of Noni Leaf Iridoids.

Dr. Johannes Westendorf – Germany
Structure and Pharmacokinetics of Iridoids in Tissue Cultures

Dr. Zsolt Petendi – Hungary
Iridoid Plants in the New Botanical System

Dr. Shixin Deng – China
LC-MS Analysis of Iridoids in Consumer Products

Brett West – United States
Antiglycation Activity of Iridoids

The conference will bring over 250 scientists, academics, and organizations together from all over the world via live webinar to share what is being discovered about the functions of iridoids in plants and animals. The conference presentations will also be posted on the Morinda Bioactive website.

Registration for this year's symposium is available at:

To view presentations from 2011, please go to:

About the Company
Morinda Bioactives (formerly Tahitian Noni International) is a global, research-driven bioactive products company that was the first to introduce the health benefits of the noni plant—a bioactive-rich, adaptogenic plant, containing iridoid compounds—to the world outside of Tahiti. Morinda Bioactives is the leader in the discovery, development, manufacturing, and marketing of noni-based bioactive products including nutritional supplements, beauty, and weight loss lines. Headquartered in Provo, Utah, Morinda Bioactives is the world-wide leader in bioactive supplements.

Andre Peterson
Director, Public Relations
(801) 234-1401

SOURCE Morinda Bioactives
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
2. Delcath Announced Changes To Board Of Directors
3. LTCLINK-Tank Competition Announced To Introduce Your Emerging Product to the Aging Care Continuum
4. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
5. Gen-Probe Withdraws from Previously Announced Investor Presentations
6. Bench International Adds Catherine Balin to Executive Team
7. NABP Stresses Need for International Collaboration to Combat Online Counterfeit Drug Distribution
8. Ellman International Launches Multi-stage Growth Plan With Acquisition Of Sandstone Medical Technologies
9. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at
10. International Drug & Explosives Detection Company Identa Corp to Dispatch First Order to Drug Store Chain
11. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: ... of chronic pain, announced today that the company will present ... held December 1-3 at the Luxe Sunset Boulevard Hotel in ... , CEO of Relmada Therapeutics, will present on Thursday, December ... . Please register at least 10 minutes ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
(Date:12/1/2015)... CHESTERBROOK, Pa. , Dec. 1, 2015 /PRNewswire/ ... leader, announced the launch of CareFront, a first-of-its-kind ... of patients diagnosed with cancer. Designed to be ... newly diagnosed cancer patients with resources for their ... costs. The program also offers tools to help ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 -- ... the company’s growing product line of food safety and seafood fraud prevention tools. ... nerka) – allow InstantLabs to offer fast, reliable species identification for the four ...
(Date:12/1/2015)... ... 01, 2015 , ... It’s official: Tattoo taboo is a thing of the ... among Millennials (a whopping one in three aged 18 to 25 is inked). As ... with their ink. In fact, RealSelf , the world’s largest community for learning ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... scale , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus ... imaging results enhancements at the Radiological Society of North America (RSNA) 2015 annual ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, VA., December 1, ... fixed price per sprint agile development contract to support the National Geospatial-Intelligence Agency's ... years, provides software engineering, infrastructure, as well as operations and sustainment support to ...
Breaking Medicine News(10 mins):